Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Bassetti

Showing results (521-530 of 742) with videos related to

Pageof 75
Sort By:
Scientific Reports|May 23, 2022
The role of kidney dysfunction in COVID-19 and the influence of ageEdoardo La Porta, Paola Baiardi, Lorenzo Fassina, et al.
Infectious Diseases and Therapy|August 7, 2025
Can We Lower the Burden of Antimicrobial Resistance (AMR) in Heavily Immunocompromised Patients? A Narrative Review and Call to ActionMatteo Bassetti, Antonella Cardone, Fatima Cardoso, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2013
Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trialEmanuele Durante-Mangoni, Giuseppe Signoriello, Roberto Andini, et al.
Journal of Global Antimicrobial Resistance|January 10, 2026
Intervention studies and antimicrobial resistance in Italy: an overview of the latest evidenceAntonio Vitiello, Andrea Zovi, Michela Sabbatucci, et al.
Frontiers in Neurology|July 5, 2021
Early Effects of Passive Leg-Raising Test, Fluid Challenge, and Norepinephrine on Cerebral Autoregulation and Oxygenation in COVID-19 Critically Ill PatientsChiara Robba, Antonio Messina, Denise Battaglini, et al.
European Journal of Internal Medicine|July 3, 2026
Sex-based differences and clinical outcomes in older adults with Candida bloodstream infection: a post-hoc secondary analysis of a multicentre studyClaudia Bartalucci, Jon Salmanton-García, Giusy Tiseo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2020
Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE TrialGeorge R Thompson, Alex Soriano, Athanasios Skoutelis, et al.
Respiratory Care|March 10, 2016
Intratracheal Administration of Antimicrobial Agents in Mechanically Ventilated Adults: An International Survey on Delivery Practices and SafetyCandela Solé-Lleonart, Jean-Jacques Rouby, Jean Chastre, et al.
Frontiers in Medicine|January 26, 2023
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19Federico Baldi, Chiara Dentone, Malgorzata Mikulska, et al.
Journal of Global Antimicrobial Resistance|May 13, 2021
Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registryGeorge G Zhanel, Rita Dhami, Melanie Baxter, et al.
Pageof 75

Showing results (521-530 of 742) with videos related to

Sort By:
Pageof 75
Scientific Reports|May 23, 2022
The role of kidney dysfunction in COVID-19 and the influence of ageEdoardo La Porta, Paola Baiardi, Lorenzo Fassina, et al.
Infectious Diseases and Therapy|August 7, 2025
Can We Lower the Burden of Antimicrobial Resistance (AMR) in Heavily Immunocompromised Patients? A Narrative Review and Call to ActionMatteo Bassetti, Antonella Cardone, Fatima Cardoso, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2013
Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trialEmanuele Durante-Mangoni, Giuseppe Signoriello, Roberto Andini, et al.
Journal of Global Antimicrobial Resistance|January 10, 2026
Intervention studies and antimicrobial resistance in Italy: an overview of the latest evidenceAntonio Vitiello, Andrea Zovi, Michela Sabbatucci, et al.
Frontiers in Neurology|July 5, 2021
Early Effects of Passive Leg-Raising Test, Fluid Challenge, and Norepinephrine on Cerebral Autoregulation and Oxygenation in COVID-19 Critically Ill PatientsChiara Robba, Antonio Messina, Denise Battaglini, et al.
European Journal of Internal Medicine|July 3, 2026
Sex-based differences and clinical outcomes in older adults with Candida bloodstream infection: a post-hoc secondary analysis of a multicentre studyClaudia Bartalucci, Jon Salmanton-García, Giusy Tiseo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2020
Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE TrialGeorge R Thompson, Alex Soriano, Athanasios Skoutelis, et al.
Respiratory Care|March 10, 2016
Intratracheal Administration of Antimicrobial Agents in Mechanically Ventilated Adults: An International Survey on Delivery Practices and SafetyCandela Solé-Lleonart, Jean-Jacques Rouby, Jean Chastre, et al.
Frontiers in Medicine|January 26, 2023
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19Federico Baldi, Chiara Dentone, Malgorzata Mikulska, et al.
Journal of Global Antimicrobial Resistance|May 13, 2021
Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registryGeorge G Zhanel, Rita Dhami, Melanie Baxter, et al.
Pageof 75